Document is current
Any future updates will be listed below
-
Authors
Wessel, Lars
Vinsensia, Maria
Koenigsmann, Thomas
Debus, Juergen
Arians, Nathalie https://orcid.org/0000-0002-2389-5404
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 20 July 2025
Accepted: 15 October 2025
First Online: 10 November 2025
Conflict of interest
: J. Debus received grants or has contracts with RaySearch Laboratories AB, Vision RT Limited, Merck Serono GmbH, Siemens Healthcare GmbH, PTW-Freiburg Dr. Pychlau GmbH, and Accuray Incorporated outside the submitted work. J. Debus is CEO of the Heidelberg Ion Therapy Center (HIT) and member of the board of directors of Heidelberg University Hospital. J. Debus holds an experimental accelerator from IntraOP. N. Arians reports speaking honoraria from IF-Kongress Management GmbH and travel grants from the German Society for Senology outside the submitted work. L. Wessel, M. Vinsensia and T. Koenigsmann declare that they have no competing interests.
